Back to search

Article

Modeling and Simulation of CAR T cell Therapy in Chronic Lymphocytic Leukemia Patients

2022-12-01

Abstract excerpt

Advances in genetic engineering have made it possible to reprogram an individual’s immune cells to express receptors that recognize markers on tumor cell surfaces. The process of re-engineering T cell lymphocytes to express Chimeric Antigen Receptors (CARs) and reinfusing the CAR-modified T cells into patients to treat various cancers is being explored in clinical trials. While the majority of patients with some c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3987201f-52c8-5239-b836-70b85a504f33
DOI
10.1101/2022.12.01.22282976
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modeling and Simulation of CAR T cell Therapy in Chronic Lymphocytic Leukemia PatientsDOI 10.1101/2022.12.01.22282976
Select a neighboring publication to make it the new centre.